Related Experiment Video

Updated: Jun 13, 2026

Analysis of Targeted Viral Protein Nanoparticles Delivered to HER2+ Tumors
11:52

Analysis of Targeted Viral Protein Nanoparticles Delivered to HER2+ Tumors

Published on: June 18, 2013

The role of HER2 in cancer therapy and targeted drug delivery

Wanyi Tai1, Rubi Mahato, Kun Cheng

  • 1Division of Pharmaceutical Sciences, School of Pharmacy, University of Missouri-Kansas City, 2464 Charlotte Street, Kansas City, MO 64108, USA.

Journal of Controlled Release : Official Journal of the Controlled Release Society
|April 14, 2010
PubMed

Insights

Human epidermal growth factor receptor 2 (HER2) is a key target in treating HER2-positive cancers like breast and gastric cancer. Research explores HER2-targeted therapies and drug delivery systems for improved treatment outcomes.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biotechnology

Background:

  • Human epidermal growth factor receptor 2 (HER2) is overexpressed in breast, ovarian, and gastric cancers, playing a crucial role in tumorigenesis.
  • The development of anti-HER2 therapies, such as Trastuzumab, has significantly advanced cancer treatment.
  • HER2's high expression and accessible extracellular domain make it a prime target for drug delivery and imaging.

Purpose of the Study:

  • To review the roles of HER2 in cancer therapy and targeted drug delivery.
  • To discuss HER2's structure, signaling pathways, and involvement in tumorigenesis.
  • To summarize current strategies for HER2-targeted cancer therapy and drug delivery systems.

Main Methods:

  • Review of scientific literature on HER2 in cancer.
  • Analysis of HER2 structure, signaling pathways, and tumorigenic roles.
  • Summary of therapeutic strategies targeting HER2, including antibody therapy, dimerization inhibitors, and kinase inhibitors.
  • Description of targeted drug delivery systems utilizing HER2 as a target.

Main Results:

  • HER2 is a validated target for cancer therapy, with multiple treatment modalities developed.
  • Targeted drug delivery systems leveraging HER2 are effective for delivering anti-tumor agents and imaging agents to HER2-positive tumor cells.
  • Artificial ligands have been developed for HER2-targeted drug delivery systems.

Conclusions:

  • HER2 remains a critical target in oncology, with ongoing advancements in therapeutic strategies.
  • Targeted delivery of therapeutics and imaging agents to HER2-positive cancers shows significant promise.
  • Further research into HER2-targeted approaches can lead to more effective cancer treatments.

More Related Videos

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery13:19

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Published on: April 26, 2024

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.